دسترسی نامحدود
برای کاربرانی که ثبت نام کرده اند
برای ارتباط با ما می توانید از طریق شماره موبایل زیر از طریق تماس و پیامک با ما در ارتباط باشید
در صورت عدم پاسخ گویی از طریق پیامک با پشتیبان در ارتباط باشید
برای کاربرانی که ثبت نام کرده اند
درصورت عدم همخوانی توضیحات با کتاب
از ساعت 7 صبح تا 10 شب
ویرایش:
نویسندگان: Lorrie Kirshenbaum (editor). Inna Rabinovich-Nikitin (editor)
سری:
ISBN (شابک) : 3031399277, 9783031399275
ناشر: Springer
سال نشر: 2023
تعداد صفحات: 441
زبان: English
فرمت فایل : PDF (درصورت درخواست کاربر به PDF، EPUB یا AZW3 تبدیل می شود)
حجم فایل: 11 مگابایت
در صورت تبدیل فایل کتاب Biology of Women’s Heart Health (Advances in Biochemistry in Health and Disease, 26) به فرمت های PDF، EPUB، AZW3، MOBI و یا DJVU می توانید به پشتیبان اطلاع دهید تا فایل مورد نظر را تبدیل نمایند.
توجه داشته باشید کتاب زیست شناسی سلامت قلب زنان (پیشرفت در بیوشیمی در سلامت و بیماری، 26) نسخه زبان اصلی می باشد و کتاب ترجمه شده به فارسی نمی باشد. وبسایت اینترنشنال لایبرری ارائه دهنده کتاب های زبان اصلی می باشد و هیچ گونه کتاب ترجمه شده یا نوشته شده به فارسی را ارائه نمی دهد.
Contents 1 The Emerging Need for Research on Women’s Heart Health The History of woman’s Health Research The Need for Woman’s Heart Health Research Understanding the Risk Factors for Cardiovascular Disease in Women Future Directions Conclusions References 2 Risk Factors for Ischemic Stroke in Women Epidemiology Sex-Specific Risk Factors for Ischemic Stroke Pregnancy or the Puerperium Period Sex-Specific Risk Factors Outside of Pregnancy or Puerperium Sex Differences in Risk Factors Shared by Men and Women Traditional Vascular Risk Factors Sex and Heart-Brain Interactions Beyond Traditional Vascular Risk Factors Clinical Implications and Future Research Summary References 3 The Effects of Sex Steroid Hormones on Cardiovascular Physiology in Females Estrogen Synthesis and Classification Genomic and Non-Genomic Effects of Estrogen Estrogens and the Cardiovascular System The Role of Estrogen in Oxidative Stress, Inflammation and Endothelial Function The Role of Estrogen in Lipid Profile Alterations, Obesity and Atherosclerosis Hormone Replacement Studies and the Timing Hypothesis The Influence of Estrogen on Endothelial Adaptations to Endurance Training Progesterone Testosterone Conclusion References 4 Spontaneous Coronary Artery Dissection (SCAD): An Overview of the Condition, Diagnostic Work Up and Management Introduction Definition and Classification of SCAD Pathophysiology of SCAD Epidemiology of SCAD Risk Factors for SCAD Clinical Presentation of SCAD What to Do if You Suspect Your Patient Has SCAD Conservative Versus Invasive Management Medical Management Outpatient Management of SCAD Patients Cardiac Rehabilitation Cardiac Rehabilitation and SCAD Patients Physical Activity After SCAD Future Directions and Opportunities References 5 Takotsubo Cardiomyopathy Introduction Definition and Diagnostic Criteria Epidemiology and Predisposing Factors Pathophysiology Clinical Presentation and Diagnostic Work Up In Hospital Risk Stratification and Complications Long Term Prognosis and Follow up Conclusion References 6 Preeclampsia: Early and Long-Term Clinical Considerations Introduction Overview Diagnosis of Preeclampsia Pathophysiology of Preeclampsia: Outcomes and Burden of Preeclampsia: Risk Factors and Primary Prevention of Preeclampsia: Antepartum Management of Preeclampsia Screening for the Development of Preeclampsia Clinical Presentation of Preeclampsia and Assessment of Complications Antepartum Management of Preeclampsia: Management During Delivery Management and Prevention of Eclampsia: Post-partum Diagnosis and Management of Preeclampsia Diagnosis of Post-partum Preeclampsia Recurrence and Secondary Prevention Lifelong Cardiovascular Risk and Outcomes Factors Associated with Lifelong Risk Screening for the Development of Cardiovascular Disease Long Term Pharmacologic Management: Statins Acetylsalicylic Acid and Angiotensin Converting Enzyme Inhibitors Summary References 7 Myocardial Infarction with Non-obstructive Coronary Artery Disease: An Overview of Definition, Classification, Diagnostic Workup and Management Introduction Definition Epidemiology Diagnostics Pathophysiologic Mechanisms Atherosclerotic Nonatherosclerotic Prognosis Conclusion Case Examples References 8 Blood Pressure: Changes Over a Woman’s Life, the Effect of Estrogen, and Special Considerations in Women Introduction Blood Pressure Effects of Endogenous Estrogens and Progesterone Hypertension in Girls and Adolescent Women Hypertension in Women of Reproductive Age Oral Contraceptives and Hypertension Polycystic Ovary Syndrome and Hypertension Hypertensive Disorders in Pregnancy Hypertension and Menopausal Hormone Therapy Sex-Specific Differences in Clinical Trials and Differences in Treating Hypertension in Women Future Directions and Unanswered Questions Conclusion References 9 Gestational Diabetes as a Risk Factor for Cardiovascular Disease Gestational Diabetes Definitions and Epidemiology Pathophysiology of Gestational Diabetes Gestational Diabetes Diagnosis and Risk Factors Complications of Gestational Diabetes Pathogenesis of Gestational Diabetes as a Risk Factor for Cardiovascular Disease Risk of Type 2 Diabetes Shared Risk Factors Other Mechanisms Epidemiology Cardiovascular Disease Risk Factors Postpartum Screening Preventing Cardiovascular Disease Following Gestational Diabetes Preventing or Delaying Type 2 Diabetes Following Gestational Diabetes Treating Cardiovascular Disease Risk Factors—Postpartum Considerations Safe Effective Contraception Future Directions References 10 Menopause and the Bridge to Cardiovascular Disease Introduction Setting the Stage: Defining Key Elements of Menopause Emergence of Risk Hormone Replacement Therapy (HRT): Restoring the “Protection”? Women’s Health Education Path Forward References 11 Vascular Dysfunction in Women Introduction Arterial Stiffness and Cardiovascular Disease Risk Sex-Specific Factors Contributing to Vascular Stiffness Sex Hormones Affecting Vascular Stiffness Post-menopause, Hormone Replacement Therapies and Oral Contraceptives Aging and Vascular Stiffness Lifestyle (Exercise and Diet) Pregnancy and Preeclampsia Psychosocial Stresses Conclusion and Future Directions References 12 Cardiometabolic Function in Women Introduction Gender Differences in Cardiovascular (CV) Risk Factors Between Men and Women The Mechanistic Basis of Gender-Specific Contributors for CMD Development Cardiometabolic Aspects in Women Hypertension in Women Sex Specific Factors that Influence Hypertension Hypertension and Menopause Hypertension and Oral Contraceptive Pills Usage Hypertension and Pregnancy Hypertension and PCOS Insulin Resistance and Diabetes Mellitus in Women Insulin Resistance, Diabetes Mellitus and Women-Specific Factors Insulin Resistance, Diabetes Mellitus and Menopause Insulin Resistance, Diabetes Mellitus and Pregnancy Insulin Resistance, Diabetes Mellitus and PCOS Obesity in Women Obesity and Women-Specific Factors Obesity and Menopause Obesity and Pregnancy Obesity and PCOS Dyslipidemia in Women Dyslipidemia and Women-Specific Factors Dyslipidemia and Pregnancy Dyslipidemia and Menopause Dyslipidemia and PCOS Conclusion References 13 Molecular Basis of the Circadian Mechanism in Women Overview of Circadian Rhythm Consequences of Circadian Misalignment in the Female Sex Potential Therapeutics and Conclusions References 14 Cardio-Rheumatology and Women’s Hearts Cardiovascular Manifestations of Rheumatic Diseases ASCVD Risk Assessment Select Conditions Disproportionately Affecting Women Rheumatoid Arthritis (RA) Systemic Lupus Erythematosus (SLE) Systemic Sclerosis (SSc) Giant Cell Arteritis (GCA) Takayasu Arteritis (TA) Osteoarthritis (OA) Other Important Considerations Ethnicity Reproductive Health Issues Societal Stigma Future Directions References 15 Cardiovascular Adverse Effects of Breast Cancer Chemotherapy Cardiovascular Complications of Chemotherapies Known Mechanisms of Doxorubicin-Induced Cardiotoxicity Doxorubicin Interacts with DNA and Topoisomerase II Doxorubicin Increases Cellular Oxidative Stress Doxorubicin Induces Cell Death Pathways Prediction and Prevention of Doxorubicin-Induced Cardiotoxicity Current Preventive Strategies for Doxorubicin-Induced Cardiotoxicity Advances in Approaches for Cardiovascular Research Pharmacogenomics and Precision Medicine Conclusion References 16 Sex-Dependent Differences in the Diagnosis, Treatment and Causes of Heart Failure Introduction History HFpEF Current Treatments Female-Specific Considerations for HF (Fig. 16.1) Diagnosing HF and Biomarkers Equity, Diversity and Inclusion (EDI) Next Steps and Suggestions Conclusion References 17 Sex-Dependent Cardiac Fibrosis After Myocardial Infarction: A Function of Differential Periostin Signaling? Introduction Myocardial Infarction and Cardiac Fibrosis in Males and Females Biology of Periostin Periostin in Post MI Cardiac Interstitial Remodeling Periostin’s Role in Male and Female Post-MI Patients Cardiovascular Disease Progression is Distinct in Male and Female Patients Summary References 18 A Narrative Review of the Vascular Consequences of Estrogen Deficiency: A Focus on Female Athletes with Functional Hypothalamic Amenorrhea Introduction Ovarian Disruption in Exercising Premenopausal Women Cardiovascular Consequences of Ovarian Dusruption in Premenopausal Women Nitric Oxide and the Endothelium: Effects of Estrogen, Exercise and Caloric Restriction Vascucular Findings in EAA: Endothelial Function Restoration of Endothelial Function in EAA Arterial Stiffness: Effects of Estrogen, Exercise and Caloric Restriction Vascular Findings in EAA: Arterial Stiffness Intima Media Thickness: Effects of Estrogen, Exercise and Caloric Restriction Vascular Findings in EAA: Intima Media Thickness Summary and Conclusion References 19 Depression and Anxiety in Women with Coronary Artery Disease: Prevalence and Links to Adverse Cardiac Outcomes The Burden of Anxiety and Depression Prevalence of Depression and Anxiety in Cardiac Disease Effects of Depression and Anxiety on Cardiac Outcomes Explanatory Mechanisms Linking Depression, Anxiety and Cardiac Outcomes Sex Differences in the Prevalence of Depression and Anxiety in Patients with Cardiac Disease Sex Differences in the Prognostic Effects of Depression and Anxiety on Adverse Cardiac Outcomes Recommendations for Future Research and Clinical Practice Conclusion References 20 Cardiac Imaging in Women with Suspected Ischemic Heart Disease Introduction Stress Echocardiography Myocardial Perfusion Imaging with SPECT and PET Single Photon Emission Computed Tomography (SPECT) Positron Emission Tomography (PET) Computed Tomography (CT) Coronary Artery Calcium Scoring Coronary CT Angiography Cardiac Magnetic Resonance Imaging (MRI) Cardiac Imaging in Pregnancy Conclusion References 21 Heart Ischemia/Reperfusion Injury—Is the Female Equally Protected Compared to Male? Introduction Conclusion References 22 Engaging Women in Decisions About Their Heart Health Introduction Shared Decision Making: Defined Shared Decision-Making and Women’s Heart Health Interventions to Facilitate Shared Decision-Making Implementation of Shared Decision-Making in Clinical Practice Conclusion and Future Directions References 23 Sex Differences in the Function of Cardiac Sodium-Calcium Exchanger in Physiological and Pathophysiological Settings: Implications for Cardiac Arrhythmias Overview of Cardiac Ca2+ Handling and Its Gender Differences The Role of the Na+/Ca2+ Exchanger in Ventricular Myocytes Sex Differences in the NCX-Expression and Genomic Regulation Sex-Related Role of NCX in Ca2+ Handling Balance Sex-Related Differences of NCX in Myocardial Ischemia Sex-Related Changes of NCX in Heart Failure Conclusion References 24 Role of Estrogen in Attenuating Apoptosis and Cardiac Dysfunction in Female Heart Failure Introduction Sex Differences in Heart Failure Effects of Estrogen and Cardiac Dysfunction in Female Heart Failure Mechanisms of Modification of Cardiomyocyte Apoptosis in Female Failing Hearts by Estrogen Treatment Experimental Evidence for the Effects of Ovariectomy and Estrogen Therapy on Cardiac Dysfunction and Apoptosis in Female Heart Failure Due to Volume Overload Conclusion References 25 Prevention of β-Adrenoceptor-Mediated Alterations in Female Heart Failure by Estrogen Introduction Role of β-AR-Signal Transduction in Heart Function Sex Differences in Cardiovascular Disease Sex Differences in the β-AR Mechanisms in Heart Failure Due to Volume Overload Conclusion References 26 Cardiovascular Consequences of Metabolic Disturbances in Women Introduction Sex Differences in Lifestyle and Risk Factors of Metabolic Syndrome Insulin Resistance and Association with Cardiovascular Diseases Sex-Related Differences in Cardiac Function Metabolic Disturbances in the Heart Induce Cardiovascular Dysfunction in Women Conclusions References